Pentwater Capital Management LP - DYNE THERAPEUTICS INC ownership

DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 84 filers reported holding DYNE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
Pentwater Capital Management LP ownership history of DYNE THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$316,000
+35.6%
15,0000.0%0.00%
+50.0%
Q1 2021$233,00015,0000.00%
Other shareholders
DYNE THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 2,960,046$28,535,00016.60%
MPM ASSET MANAGEMENT LLC 4,951,303$47,731,00016.31%
Atlas Venture Life Science Advisors, LLC 8,934,902$86,132,00010.89%
Logos Global Management LP 2,734,392$26,360,0003.42%
Deep Track Capital, LP 3,500,000$33,740,0002.16%
Octagon Capital Advisors LP 525,284$5,064,0001.10%
HighVista Strategies LLC 168,691$1,626,0001.03%
Monashee Investment Management LLC 279,704$2,696,0000.78%
COMMODORE CAPITAL LP 305,125$2,941,0000.66%
RA Capital Management 2,805,045$27,041,0000.59%
View complete list of DYNE THERAPEUTICS INC shareholders